chr6-150887842-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015440.5(MTHFD1L):c.644-3T>C variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000051 in 1,589,294 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015440.5 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MTHFD1L | NM_015440.5 | c.644-3T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000367321.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MTHFD1L | ENST00000367321.8 | c.644-3T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_015440.5 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000698 AC: 16AN: 229292Hom.: 0 AF XY: 0.0000564 AC XY: 7AN XY: 124098
GnomAD4 exome AF: 0.0000466 AC: 67AN: 1436962Hom.: 0 Cov.: 30 AF XY: 0.0000406 AC XY: 29AN XY: 714544
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.644T>C (p.V215A) alteration is located in exon 7 (coding exon 7) of the MTHFD1L gene. This alteration results from a T to C substitution at nucleotide position 644, causing the valine (V) at amino acid position 215 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at